Back
Chesapeake Energy 10K Form
Sell
44
CHK
Chesapeake Energy
Last Price:
78.39
Seasonality Move:
-0.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-31 | 10Q | CHK/Chesapeake Energy Quarterly |
| 2023-08-01 | 10Q | CHK/Chesapeake Energy Quarterly |
| 2023-05-02 | 10Q | CHK/Chesapeake Energy Quarterly |
| 2023-02-22 | 10K | CHK/Chesapeake Energy Annual |
| 2022-11-01 | 10Q | CHK/Chesapeake Energy Quarterly |
| 2022-08-02 | 10Q | CHK/Chesapeake Energy Quarterly |
Receive CHK News And Ratings
See the #1 stock for the next 7 days that we like better than CHK
CHK Financial Statistics
Sales & Book Value
| Annual Sales: | $11.44B |
|---|---|
| Cash Flow: | $83M |
| Price / Cash Flow: | 11.83 |
| Annual Sales: | $78.27 |
| Price / Book: | 1.03 |
Profitability
| EPS (TTM): | 36.82000 |
|---|---|
| Net Income (TTM): | $5.43B |
| Gross Margin: | $3.7B |
| Return on Equity: | 58.49% |
| Return on Assets: | 37.28% |
Chesapeake Energy Earnings Forecast
Key Chesapeake Energy Financial Ratios
- The Gross Profit Margin over the past 29 years for CHK is 32.33%.
- The Selling, General & Administrative Expenses for CHK have been equal to 1.24% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 3.30% of Operating Income.
- The Net Earning history of CHK is 43.14% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 15 years.
Chesapeake Energy Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Oil & Gas E&P |
| Sector: | Energy |
| Current Symbol: | CHK |
| CUSIP: | 165167 |
| Website: | chk.com |
Debt
| Debt-to-Equity Ratio: | 0.2 |
|---|---|
| Current Ratio: | 1.56 |
| Quick Ratio: | 0.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.42 |
|---|---|
| Forward P/E Ratio: | 14.77 |
CHK Technical Analysis vs Fundamental Analysis
Sell
44
Chesapeake Energy (CHK)
is a Sell
Is Chesapeake Energy a Buy or a Sell?
-
Chesapeake Energy stock is rated a Sell
The current Chesapeake Energy [CHK] share price is $80.60. The Score for CHK is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.